Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IIR-16007894Phase 2Completed
Phase 2, randomised trial of Aminazin, sulpiride, clozapine, risperidone, haloperidol and 2 more in schizophrenia (3 arms), sponsored by Fengtai Nanyuan Hospital. Primary endpoint: aggressive behavior. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IIR-16007894.